John Markels

John Markels, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Sangamo Therapeutics, Inc and Arcturus Therapeutics Holdings Inc. The record holds 8 filings, for trades running from 11 February 2020 to 12 June 2025.

Purchases make up the whole of the open-market record (1 purchase, €23k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 6 share grants and 1 option exercise.

Most recently, on 16 June 2025, the filings show a share grant in Sangamo Therapeutics, Inc. The last purchase on record was published on 6 June 2022, which is 1,601 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.